Business Wire

Robin.io Platform on QCT Servers Accelerates Cloud-native Transformation

Share

Quanta Cloud Technology (QCT), a global data center solution provider, announced IronCloud — Robin Cloud Platform, its latest addition to its 5G solutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210701005022/en/

The partnership between QCT and Robin helps customers accelerate their cloud-native transformations. The solution is built on the Robin.io’s Multi-Data Center Automation Platform (MDCAP) and Cloud Native Platform (CNP), a comprehensive carrier-grade bare-metal to services orchestration and enhanced Kubernetes platform, for 5G and Multi-access Edge Computing (MEC) applications. The solution harmonizes virtual machines and containers, enabling unprecedented resource sharing with easy to use, unified workflows and lifecycle automation that is customer proven to reduce both CAPEX and OPEX. All of this is deployable on QCT servers using 3rd Gen Intel Xeon Scalable processors.

To accelerate cloud-native transformations, QCT and Robin have developed a centralized automation platform using hardware, network acceleration technologies and best practices for orchestration, automation and lifecycle management. The result is an optimized solution that utilizes a cloud-native infrastructure for Telco workloads that supports both virtual machines and containers, in the same resource sharing cluster, from regional data center to far edge. Operators and enterprises can reliably reach the high throughput and low latency required by cloud-native 5G applications (i.e., Core, RAN and CDN). This partnership reduces the challenges of deploying and managing networks, while providing an optimized, cost-efficient infrastructure.

IronCloud — Robin Cloud Platform features the following 3rd Gen Intel Xeon Scalable processor-based servers:

“Lifecycle management and automation are keys to reducing 5G infrastructure and operation costs,” said Mike Yang, president of QCT. “By partnering with Robin.io, we have created an automated cloud-native platform, IronCloud, for our mutual customers to boost 5G application time to market.”

“Our partners are creating optimized, performant and automated solutions that accelerate the path to cloud-native for 5G,” stated Keate Despain, Intel Network Builders and Ecosystem Programs Director. “The IronCloud — Robin Cloud Platform is a solution that will enable companies to deliver an end-to-end cloud native platform and a 5G service delivery network at cost savings.”

“Cloud-Native technology has proven benefits for 5G economics,” said Partha Seetala, CEO and founder of Robin.io. “Our close relationships with QCT and Intel have delivered a production-ready open and extensible platform for deployment and life cycle management. It’s an entire Telco Network Stack, with both CNFs and VNFs that offers industry leading TCO.”

About QCT

QCT is a global data center solution provider that combines the efficiency of hyperscale hardware with infrastructure software from a diversity of industry leaders to solve next-generation data center design and operational challenges. QCT serves cloud service providers, telecoms and enterprises running public, hybrid and private clouds. The parent of QCT is Quanta Computer, Inc., a Fortune Global 500 corporation. www.qct.io

About Robin.io

Robin.io, the 5G and application automation platform company, delivers products that automate the deployment, scaling and life cycle management of data- and network-intensive applications and for 5G service chains across edge, core and RAN. The Robin platform is used globally by companies including BNP Paribas, Palo Alto Networks, Rakuten Mobile, SAP, Sabre and USAA. Robin.io is headquartered in Silicon Valley, California. More at www.robin.io and Twitter: @robin4K8S.

Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Danny Chang (QCT)
Danny_Chang@quantatw.com

Robert Cathey (Cathey.co for Robin.io)
robert@cathey.co

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

iXensor Levels Up PixoTest ® COVID-19 Ag Test With the Launch of PixoHealth Data Management P latform as the Security Solution for the New Normalcy27.7.2021 08:30:00 CEST | Press release

iXensor Co., Ltd. (6734.TWO) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210726005852/en/ PixoHealth Pass Admin Solution empowers sustainable, safe reopening together with PixoTest POCT COVID-19 Antigen Test. (Photo: Business Wire) iXensor launches the next generation of integrated COVID-19 screening solution, the PixoHealth Pass Admin App and Web Portal. The PixoHealth Pass Admin App is a virtual gatekeeper, which screens and verifies the COVID-19 related health conditions through a scan of QR code displayed by PixoHealth Pass App users. In addition, the PixoHealth Pass Admin Web Portal synchronizes multi-source COVID-19 related health data and rapid test results from PixoHealth Pass App users and PixoTest® POCT Analyzer simultaneously. With PixoHealth Pass apps and in-app consent, the authorized institution can track app users’ rapid test results, vaccination status and COVID-19 related symptoms directly on the web port

TA Associates Announces Strategic Growth Investment in Elos Medtech27.7.2021 07:30:00 CEST | Press release

TA Associates, a leading global growth private equity firm, today announced it has completed a majority growth investment in Elos Medtech AB (NASDAQ STOCKHOLM: ELOS B), a leading innovative full-service contract development and manufacturing organization (CDMO) in the global medical device market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210726005835/en/ Founded in 1923, Elos Medtech is headquartered in Gothenburg, Sweden with operations being conducted at facilities in Sweden, Denmark, China and the U.S. As a global solutions partner offering complete performance and vertical integration to leading medical device companies worldwide, Elos Medtech serves the dental, orthopaedic and life science markets. In long-term partnership with their customers, Elos Medtech provides sustainable and innovative products and supply solutions for the global medical device and life science market. “We have followed Elos Medtech for sev

Ricardo Supports Mexico in Drive to Reduce Freight Emissions27.7.2021 07:01:00 CEST | Press release

Experts from global energy and environment consultancy Ricardo are leading an international consortium to support the Mexican Government’s plan to reduce greenhouse gas (GHG) emissions in the freight sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210726005697/en/ Ricardo supports Mexico in drive to reduce freight emissions (Photo: Business Wire) Over the next 12 months, specialists in sustainable transport will work with organisations, including Mexico-based Centro Mario Molina and Urbanistica, to provide advice to the German Agency for International Cooperation (GIZ) as part of the Sustainable Transport Programme. The country’s commitment to reducing GHGs by 22% by 2030 depends on the successful decarbonisation of its transport sector, which contributes to 25% of total CO2 emissions nationally. Road activity is responsible for 97% of all transport emissions and freight transport plays a key role by moving nearly 75%

Cat Rock Capital Issues Presentation on Just Eat Takeaway.com27.7.2021 07:00:00 CEST | Press release

Cat Rock Capital Management LP (together with its affiliates, “Cat Rock Capital”), a long-term oriented investment firm and beneficial owner of approximately 10.0 million shares of the common stock of Just Eat Takeaway.com NV (“Just Eat Takeaway.com”, “JET”, or “the Company”) (LSE: JET, AMS: TKWY, NASDAQ: GRUB), representing circa 4.7% of Just Eat Takeaway.com’s outstanding shares, today issues a public presentation on recent developments at the Company. This presentation is available at JustEatMustDeliver.com and upon request via info@catrockcap.com. Cat Rock Capital also comments: “Cat Rock Capital has been a shareholder of Just Eat Takeaway.com and its predecessor companies for over four years, and we have intensively researched the global online food delivery sector over the past six years. “We believe JET is a fantastic online food delivery business with #1 positions in markets representing 90% of its revenue,(1) a huge runway for continued organic growth, and highly experienced o

Logitech Delivers Strong Start to Fiscal Year 202227.7.2021 03:00:00 CEST | Press release

SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2022. Q1 sales were $1.31 billion, up 66 percent in US dollars and 58 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 143 percent to $203 million, compared to $83 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 160 percent to $1.09, compared to $0.42 in the same quarter a year ago. Q1 non-GAAP operating income grew 100 percent to $235 million, compared to $117 million in the same quarter a year ago. Q1 non-GAAP EPS grew 91 percent to $1.22, compared to $0.64 in the same quarter a year ago. “We’ve started strong in Fiscal Year 2022, with Q1 sales up 58% in constant currency and profits doubling versus last year,” said Bracken Darrell, Logitech president and chief executive officer. “Our key categories grew high double digits. This

Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets26.7.2021 22:05:00 CEST | Press release

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced a partnership agreement with Biocon Biologics Ltd., to combat the ongoing COVID-19 crisis in southern Asia. Biocon Biologics Ltd. is a fully integrated biosimilars company and a subsidiary of Biocon Ltd., a global biopharmaceuticals company, (BSE code: 532523, NSE: BIOCON). Under the terms of the agreement, Adagio will provide Biocon with materials and know-how to manufacture and commercialize an antibody treatment based on ADG20 in India and additional select emerging markets. ADG20, Adagio’s lead product candidate, is designed to be a potent, long-acting and broadly neutralizing antibody for both the treatment and prevention of COVID-19 as either a single or combination agent. Unlike other antibody-based therapies specifically targeting SARS-CoV-2, ADG20 has demons

SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis26.7.2021 18:40:00 CEST | Press release

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have launched a new product line of research reagents to support reflex variant analysis for circulating SARS-CoV-2 variants of concern (VOC). The rapid development of PlexPrime® SARS-CoV-2 Genotyping* tests will support investigations and monitoring of the range of emerging and circulating SARS-CoV-2 VOC that have been linked to increased transmissibility, reduced vaccine efficacy, or other characteristics that may require specific public health actions.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210726005313/en/ SpeeDx unique technology excels in mutation detection applications and can readily be applied to variants reported in the SARS-CoV-2 sequence databases. Compatible with standard qPCR instrumentation, the PlexPrime® SARS-CoV-2 Genotyping research reagents can reduce the manual process of preparing positive samples for sequence analysis